

It is a privilege to report on the progress of Mediclinic during the last financial year. Mediclinic is a company that was listed on the JSE in 1986 with a market capitalisation of R170m which has currently grown to around R24bn.
The period under review was a challenging year, especially with the various regulatory changes in Switzerland. Despite the challenges and uncertainties, the Group achieved good revenue growth in Southern Africa and Switzerland and exceptional growth in Dubai.
READ REPORT
The Group delivered solid financial results and growth for 2012, despite continuing challenging global economic conditions.
READ REPORT
> Full annual report - 3.7MB
> Annual financial statements - 1.8MB
> Overview - 1.7MB
> Report profile - 2.4MB
> Performance highlights - 1.2MB
> Value added statement - 1.2MB
> Organisational overview - 1.3MB
> Board of directors - 1.4MB
> Our vision and values - 1.2MB
> Strategic objectives - 1.2MB
> Investment case - 1.2MB
> Seven-year review - 1.2MB
> Performance and future outlook - 1.5MB
> Chairman's Report - 1.3MB